Western blot analysis was performed on whole cell extracts (30 µg lysate) of PC-3 (Lane 1), NTERA-2 (Lane 2), A-431 (Lane 3), MCF7 (Lane 4), Caco-2 (Lane 5), A549 ( Lane 6), SH-SY5Y (Lane 7) and HeLa (Lane 8). The blots were probed with Anti-SF2 / ASF Mouse Monoclonal Antibody (Product # 32-4500, 2 µg/ml) and detected by chemiluminescence using Goat anti-Mouse IgG (H+L) Superclonal™ Secondary Antibody, HRP conjµgate (Product # A28177, 0.4 µg/ml, 1:2500 dilution). A 32 kDa band corresponding to SF2 / ASF was observed across the cell lines tested. Known quantity of protein samples were electrophoresed using Novex® NuPAGE® 10 % Bis-Tris gel (Product # NP0302BOX), XCell SureLock™ Electrophoresis System (Product # EI0002) and Novex® Sharp Pre-Stained Protein Standard (Product # LC5800). Resolved proteins were then transferred onto a nitrocellulose membrane with iBlot® 2 Dry Blotting System (Product # IB21001). The membrane was probed with the relevant primary and secondary Antibody following blocking with 5 % skimmed milk. Chemiluminescent detection was performed using Novex® ECL Chemiluminescent Substrate Reagent Kit (Product # WP20005).
|Tested species reactivity||Human, Mouse, Rat|
|Published species reactivity||Rat, Human, Mouse, Not Applicable|
|Host / Isotype||Mouse / IgG2b|
|Immunogen||Recombinant SF2/ASF protein.|
|Storage buffer||PBS, pH 7.4|
|Contains||0.1% sodium azide|
|Tested Applications||Dilution *|
|Flow Cytometry (Flow)||3-5 µg/10^6 cells|
|Immunofluorescence (IF)||Assay Dependent|
|Immunoprecipitation (IP)||Assay Dependent|
|Western Blot (WB)||2 µg/ml|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
|Western Blot (WB)||See 15 publications below|
|Immunohistochemistry (IHC)||See 1 publications below|
|ChIP assay (ChIP)||See 2 publications below|
|Immunoprecipitation (IP)||See 4 publications below|
|Miscellaneous PubMed (MISC)||See 4 publications below|
|Immunofluorescence (IF)||See 1 publications below|
This gene encodes a member of the arginine/serine-rich splicing factor protein family, and functions in both constitutive and alternative pre-mRNA splicing. The protein binds to pre-mRNA transcripts and components of the spliceosome, and can either activate or repress splicing depending on the location of the pre-mRNA binding site. The protein's ability to activate splicing is regulated by phosphorylation and interactions with other splicing factor associated proteins. Multiple transcript variants encoding different isoforms have been found for this gene.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
|Not Applicable||Not Cited||
The alternative splicing program of differentiated smooth muscle cells involves concerted non-productive splicing of post-transcriptional regulators.
32-4500 was used in western blot to characterize the involvement of concerted non-productive splicing of post-transcriptional regulators that involves the alternative splicing program of differentiatied smooth muscle cells
|Llorian M,Gooding C,Bellora N,Hallegger M,Buckroyd A,Wang X,Rajgor D,Kayikci M,Feltham J,Ule J,Eyras E,Smith CW||Nucleic acids research (44:8933)||2016|
Rescue of Isolated GH Deficiency Type II (IGHD II) via Pharmacologic Modulation of GH-1 Splicing.
32-4500 was used in western blot to research pharmacologic modulation of GH-1 splicing due to rescue of isolated growth hormone deficiency type II (IGHD II)
|Miletta MC,Petkovic V,Eblé A,Flück CE,Mullis PE||Endocrinology (157:3972)||2016|
Human Papillomavirus E2 Regulates SRSF3 (SRp20) To Promote Capsid Protein Expression in Infected Differentiated Keratinocytes.
32-4500 was used in western blot to assess regulation of SRSF3 (SRp20) to promote capsid protein expression in infected differentiated keratinocytes by human papillomavirus E2
|Klymenko T,Hernandez-Lopez H,MacDonald AI,Bodily JM,Graham SV||Journal of virology (90:5047)||2016|
SRSF1 and hnRNP H antagonistically regulate splicing of COLQ exon 16 in a congenital myasthenic syndrome.
32-4500 was used in western blot to characterize acetylcholinesterase mutations.
|Rahman MA,Azuma Y,Nasrin F,Takeda J,Nazim M,Bin Ahsan K,Masuda A,Engel AG,Ohno K||Scientific reports (5:null)||2015|
Splice-shifting oligonucleotide (SSO) mediated blocking of an exonic splicing enhancer (ESE) created by the prevalent c.903+469T>C MTRR mutation corrects splicing and restores enzyme activity in patient cells.
32-4500 was used in western blot to investigate the therapeutic potential of splicinge-shifting oligonucleotide in the cblE type of homocystinuria
|Palhais B,Præstegaard VS,Sabaratnam R,Doktor TK,Lutz S,Burda P,Suormala T,Baumgartner M,Fowler B,Bruun GH,Andersen HS,Ko¿ich V,Andresen BS||Nucleic acids research (43:4627)||2015|
Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
32-4500 was used in western blot to study the regulation of the human papillomavirus 16 oncoprotein expression
|McFarlane M,MacDonald AI,Stevenson A,Graham SV||Journal of virology (89:5276)||2015|
|Not Applicable||Not Cited||
Attenuation of the suppressive activity of cellular splicing factor SRSF3 by Kaposi sarcoma-associated herpesvirus ORF57 protein is required for RNA splicing.
32-4500 was used in western blot to study Kaposi sarcoma-associated herpesvirus ORF57 protein attenuates the suppressive activity of cellular splicing factor SRSF3 and is required by RNA splicing
|Majerciak V,Lu M,Li X,Zheng ZM||RNA (New York, N.Y.) (20:1747)||2014|
Eight nucleotide substitutions inhibit splicing to HPV-16 3'-splice site SA3358 and reduce the efficiency by which HPV-16 increases the life span of primary human keratinocytes.
32-4500 was used in western blot to investigate the HPV-16 splicing and its effect on primary human keratinocytes
|Li X,Johansson C,Cardoso Palacios C,Mossberg A,Dhanjal S,Bergvall M,Schwartz S||PloS one (8:null)||2013|
A synonymous polymorphic variation in ACADM exon 11 affects splicing efficiency and may affect fatty acid oxidation.
32-4500 was used in western blot to study a single-nucleotide polymorphism, rs278C to T, located far upstream of the MCAD gene.
|Bruun GH,Doktor TK,Andresen BS||Molecular genetics and metabolism (110:122)||2013|
A retroelement modifies pre-mRNA splicing: the murine Glrb(spa) allele is a splicing signal polymorphism amplified by long interspersed nuclear element insertion.
32-4500 was used in western blot to assess the effect of the Glrb(spa) LINE insertion on pre-mRNA splicing.
|Becker K,Braune M,Benderska N,Buratti E,Baralle F,Villmann C,Stamm S,Eulenburg V,Becker CM||The Journal of biological chemistry (287:31185)||2012|
Resveratrol, by modulating RNA processing factor levels, can influence the alternative splicing of pre-mRNAs.
32-4500 was used in western blot to report that resveratrol modulates alternative splicing in a target-specific manner.
|Markus MA,Marques FZ,Morris BJ||PloS one (6:null)||2011|
|Human||Not Cited||A conserved splicing mechanism of the LMNA gene controls premature aging.||Lopez-Mejia IC,Vautrot V,De Toledo M,Behm-Ansmant I,Bourgeois CF,Navarro CL,Osorio FG,Freije JM,Stévenin J,De Sandre-Giovannoli A,Lopez-Otin C,Lévy N,Branlant C,Tazi J||Human molecular genetics (20:4540)||2011|
|Coupled transcription-splicing regulation of mutually exclusive splicing events at the 5' exons of protein 4.1R gene.||Huang SC,Cho A,Norton S,Liu ES,Park J,Zhou A,Munagala ID,Ou AC,Yang G,Wickrema A,Tang TK,Benz EJ||Blood (114:4233)||2009|
Alteration of cellular RNA splicing and polyadenylation machineries during productive human cytomegalovirus infection.
32-4500 was used in western blot to study human cytomegalovirus UL37 isoforms
|Adair R,Liebisch GW,Su Y,Colberg-Poley AM||The Journal of general virology (85:3541)||2004|
|Mouse||Not Cited||RNA folding affects the recruitment of SR proteins by mouse and human polypurinic enhancer elements in the fibronectin EDA exon.||Buratti E,Muro AF,Giombi M,Gherbassi D,Iaconcig A,Baralle FE||Molecular and cellular biology (24:1387)||2004|
|Not Applicable||Not Cited||
A genome landscape of SRSF3-regulated splicing events and gene expression in human osteosarcoma U2OS cells.
32-4500 was used in immunohistochemistry and western blot to characterize human osteosarcoma U2OS cells for genome landscape of SRSF3-regulated splicing events and gene expression
|Ajiro M,Jia R,Yang Y,Zhu J,Zheng ZM||Nucleic acids research (44:1854)||2016|
Alanine repeats influence protein localization in splicing speckles and paraspeckles.
32-4500 was used in ChIP assay to investigate the function of the alanine repeat-containing C-terminal domain of RNA-binding motif protein 4
|Chang SH,Chang WL,Lu CC,Tarn WY||Nucleic acids research (42:13788)||2014|
|Not Applicable||Not Cited||
The splicing factor SF2/ASF binds to ARS homologs in a human rDNA replication origin.
32-4500 was used in ChIP assay to investigate the mechanisms by which SF2/ASF contributes to oncogenesis
|He M,Shah D,Choung HY,Coffman FD||Cell cycle (Georgetown, Tex.) (8:2631)||2009|
Identification by high-throughput imaging of the histone methyltransferase EHMT2 as an epigenetic regulator of VEGFA alternative splicing.
32-4500 was used in immunoprecipitation to study the function of histone methyltransferase EHMT2 in VEGFA alternative splicing
|Salton M,Voss TC,Misteli T||Nucleic acids research (42:13662)||2014|
|Not Applicable||Not Cited||
Identification of the adenovirus E4orf4 protein binding site on the B55¿ and Cdc55 regulatory subunits of PP2A: Implications for PP2A function, tumor cell killing and viral replication.
32-4500 was used in immunoprecipitation and western blot to identify the adenovirus E4orf4 protein binding site on the B55alpha and Cdc55 regulatory subunits of P22A and its tumor cell killing and viral replication function
|Mui MZ,Kucharski M,Miron MJ,Hur WS,Berghuis AM,Blanchette P,Branton PE||PLoS pathogens (9:null)||2013|
||RNA folding affects the recruitment of SR proteins by mouse and human polypurinic enhancer elements in the fibronectin EDA exon.||Buratti E,Muro AF,Giombi M,Gherbassi D,Iaconcig A,Baralle FE||Molecular and cellular biology (24:1387)||2004|
|Human||Not Cited||Roles for SR proteins and hnRNP A1 in the regulation of c-src exon N1.||Rooke N,Markovtsov V,Cagavi E,Black DL||Molecular and cellular biology (23:1874)||2003|
Paraquat modulates alternative pre-mRNA splicing by modifying the intracellular distribution of SRPK2.
32-4500 was used in western blot to explore the mechanism underlying paraquat-induced pre-mRNA splicing alterations.
|Vivarelli S,Lenzken SC,Ruepp MD,Ranzini F,Maffioletti A,Alvarez R,Mühlemann O,Barabino SM||PloS one (8:null)||2013|
Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma.
32-4500 was used in immunohistochemistry (paraffin) to study SRSF1 and SRSF2 in lung cancer.
|Gout S,Brambilla E,Boudria A,Drissi R,Lantuejoul S,Gazzeri S,Eymin B||PloS one (7:null)||2012|
Psip1/Ledgf p52 binds methylated histone H3K36 and splicing factors and contributes to the regulation of alternative splicing.
32-4500 was used in ChIP assay and western blot to elucidate the role of Psip1/p52 in splicing.
|Pradeepa MM,Sutherland HG,Ule J,Grimes GR,Bickmore WA||PLoS genetics (8:null)||2012|
Disturbed expression of splicing factors in renal cancer affects alternative splicing of apoptosis regulators, oncogenes, and tumor suppressors.
32-4500 was used in western blot to discuss how alternative splicing contributes to clear cell renal cell carcinoma
|Piekielko-Witkowska A,Wiszomirska H,Wojcicka A,Poplawski P,Boguslawska J,Tanski Z,Nauman A||PloS one (5:null)||2010|
|Rat||Not Cited||RNA splicing capability of live neuronal dendrites.||Glanzer J,Miyashiro KY,Sul JY,Barrett L,Belt B,Haydon P,Eberwine J||Proceedings of the National Academy of Sciences of the United States of America (102:16859)||2005|